# LMND (Lemonade, Inc.) - SEC EDGAR Financial Statements

> Lemonade, Inc. reported $1.12B in revenue and a net loss of $144.6M for the trailing twelve months ended September 30, 2026 (up 72.8% year over year).

- Canonical: https://convexityos.com/fundamentals/LMND
- Markdown: https://convexityos.com/fundamentals/LMND.md
- SEC CIK: 0001691421
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:20 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001691421&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $1.12B | +72.8% YoY |
| Operating Income | TTM | -- | Operating profit |
| Net Income | TTM | -$144.6M | -13.0% net margin |
| Diluted EPS | TTM | -$1.86 | Split-adjusted |
| Free Cash Flow | TTM | $7.40M | 0.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $442.0M | Total debt: $18.00M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $737.9M | $526.5M | $429.8M | $256.7M | $128.4M | $94.40M | $67.30M | $22.50M |
| Research & Development | $93.90M | $85.80M | $88.80M | $79.60M | $51.80M | $19.40M | $9.80M | $4.70M |
| Selling, General & Admin | $364.2M | $290.8M | $231.2M | $260.6M | $214.2M | $126.7M | $110.0M | $51.00M |
| Income Before Tax | -$160.9M | -$203.9M | -$229.8M | -$294.8M | -$233.6M | -$120.8M | -$107.9M | -$52.60M |
| Income Tax Expense | $4.60M | -$1.70M | $7.10M | $3.00M | $7.70M | $1.50M | $600K | $300K |
| **Net Income** | -$165.5M | -$202.2M | -$236.9M | -$297.8M | -$241.3M | -$122.3M | -$108.5M | -$52.90M |
| Basic EPS | -$2.24 | -$2.85 | -$3.40 | -$4.59 | -$3.94 | -$3.63 | -$9.75 | -$4.84 |
| **Diluted EPS** | -$2.24 | -$2.85 | -$3.40 | -$4.59 | -$3.94 | -$3.63 | -$9.75 | -$4.84 |
| Basic Shares Outstanding | 73.9M | 71.0M | 69.7M | 64.9M | 61.2M | 33.7M | 11.1M | 10.9M |
| Diluted Shares Outstanding | 73.9M | 71.0M | 69.7M | 64.9M | 61.2M | 33.7M | 11.1M | 10.9M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $336.1M | $294.4M | $258.0M | $228.1M | $194.5M | $164.1M | $151.2M | $148.8M |
| Research & Development | $29.20M | $30.00M | $26.90M | $24.80M | $24.70M | $22.40M | $22.00M | $21.80M |
| Selling, General & Admin | $133.5M | $125.5M | $108.3M | $107.3M | $92.40M | $85.40M | $79.10M | $81.20M |
| Income Before Tax | -$43.20M | -$41.80M | -$34.60M | -$20.60M | -$36.30M | -$42.60M | -$61.40M | -$37.80M |
| Income Tax Expense | $500K | $1.60M | $1.20M | $1.10M | $1.20M | $1.30M | $1.00M | -$7.80M |
| **Net Income** | -$43.70M | -$43.40M | -$35.80M | -$21.70M | -$37.50M | -$43.90M | -$62.40M | -$30.00M |
| Basic EPS | -$0.56 | -$0.56 | -$0.47 | -- | -$0.51 | -$0.60 | -$0.86 | -- |
| **Diluted EPS** | -$0.56 | -$0.56 | -$0.47 | -- | -$0.51 | -$0.60 | -$0.86 | -- |
| Basic Shares Outstanding | 77.5M | 77.0M | 76.3M | -- | 74.2M | 73.4M | 72.9M | -- |
| Diluted Shares Outstanding | 77.5M | 77.0M | 76.3M | -- | 74.2M | 73.4M | 72.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $385.0M | $376.0M | $264.5M | $282.5M | $270.6M | $570.8M | $270.0M |
| Short-Term Investments | $14.10M | $27.50M | $45.80M | $99.80M | $110.4M | $0 | $54.70M |
| **Cash & Short-Term Investments** | $399.1M | $403.5M | $310.3M | $382.3M | $381.0M | $570.8M | $324.7M |
| Property, Plant & Equipment, Net | $15.80M | $16.10M | $17.40M | $19.60M | $11.70M | $5.70M | $3.10M |
| Goodwill | $19.00M | $19.00M | $19.00M | $19.00M | $0 | -- | -- |
| Intangible Assets | $8.10M | $13.60M | $22.90M | $32.50M | $600K | -- | -- |
| **Total Assets** | $1.93B | $1.85B | $1.63B | $1.69B | $1.51B | $828.7M | $414.3M |
| **Total Liabilities** | $1.39B | $1.26B | $924.4M | $823.9M | $522.3M | $287.7M | $116.6M |
| **Total Debt (incl. Leases)** | $24.00M | $23.80M | $28.20M | $35.20M | $22.30M | -- | -- |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1.46B | -$1.30B | -$1.10B | -$859.7M | -$561.9M | -$320.6M | -$198.3M |
| Accumulated Other Comp. Income | $6.40M | -$6.10M | -$9.00M | -$27.60M | -$3.40M | $1.80M | $100K |
| **Total Stockholders' Equity** | $533.6M | $593.4M | $708.9M | $866.8M | $988.2M | $541.0M | -$182.5M |
| Total Equity | $533.6M | $593.4M | $708.9M | $866.8M | $988.2M | $541.0M | -$182.5M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $369.2M | $367.6M | $374.3M | $385.0M | $345.9M | $377.5M | $309.2M | $376.0M |
| Short-Term Investments | $72.80M | $9.20M | $19.50M | $14.10M | $23.50M | $21.30M | $20.50M | $27.50M |
| **Cash & Short-Term Investments** | $442.0M | $376.8M | $393.8M | $399.1M | $369.4M | $398.8M | $329.7M | $403.5M |
| Property, Plant & Equipment, Net | $21.80M | $18.90M | $16.70M | $15.80M | $15.30M | $16.00M | $16.20M | $16.10M |
| Goodwill | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M | $19.00M |
| Intangible Assets | $8.10M | $8.10M | $8.10M | $8.10M | $8.10M | $8.80M | $11.20M | $13.60M |
| **Total Assets** | $2.09B | $2.01B | $1.96B | $1.93B | $1.92B | $1.93B | $1.86B | $1.85B |
| **Total Liabilities** | $1.62B | $1.51B | $1.44B | $1.39B | $1.40B | $1.41B | $1.31B | $1.26B |
| **Total Debt (incl. Leases)** | $18.00M | $20.00M | $20.80M | $24.00M | $12.70M | $20.20M | $21.80M | $23.80M |
| Common Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Retained Earnings | -$1.59B | -$1.54B | -$1.50B | -$1.46B | -$1.44B | -$1.41B | -$1.36B | -$1.30B |
| Accumulated Other Comp. Income | -$10.40M | -$300K | $700K | $6.40M | $5.20M | $4.20M | -$3.40M | -$6.10M |
| **Total Stockholders' Equity** | $471.8M | $499.5M | $518.0M | $533.6M | $516.2M | $527.1M | $545.5M | $593.4M |
| Total Equity | $471.8M | $499.5M | $518.0M | $533.6M | $516.2M | $527.1M | $545.5M | $593.4M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$165.5M | -$202.2M | -$236.9M | -$297.8M | -$241.3M | -$122.3M | -$108.5M | -$52.90M |
| Depreciation & Amortization | $15.20M | $20.00M | $20.00M | $12.20M | $3.70M | $1.70M | $600K | $100K |
| Stock-Based Compensation | $61.30M | $64.50M | $59.90M | $59.30M | $44.10M | $10.60M | $4.30M | $2.10M |
| Change in Payables | -$4.00M | $3.90M | -$500K | -$700K | -$400K | $700K | -$800K | $200K |
| **Operating Cash Flow** | -$16.50M | -$11.40M | -$119.1M | -$163.0M | -$144.6M | -$91.70M | -$78.10M | -$40.80M |
| Capital Expenditure | -$9.40M | -$9.40M | -$9.20M | -$10.10M | -$9.40M | -$4.40M | -$2.70M | -$700K |
| **Free Cash Flow** | -$25.90M | -$20.80M | -$128.3M | -$173.1M | -$154.0M | -$96.10M | -$80.80M | -$41.50M |
| Acquisitions, Net | -- | $0 | $0 | $98.80M | $0 | $0 | -- | -- |
| Purchases of Investments | -$476.7M | -$305.7M | -$323.7M | -$133.4M | -$712.0M | -$2.90M | -$3.50M | $0 |
| **Investing Cash Flow** | -$89.10M | $40.60M | $88.70M | $181.1M | -$804.8M | $50.10M | -$54.00M | $6.40M |
| **Financing Cash Flow** | $106.6M | $87.70M | $15.40M | $3.60M | $649.6M | $341.1M | $300.1M | $119.9M |
| **Net Change in Cash** | $11.10M | $114.2M | -$15.00M | $15.90M | -$300.8M | $301.1M | $167.9M | $85.50M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$43.70M | -$43.40M | -$35.80M | -$21.70M | -$37.50M | -$43.90M | -$62.40M | -$30.00M |
| Depreciation & Amortization | $2.60M | $2.40M | $2.70M | $2.60M | $3.40M | $4.70M | $4.50M | $4.70M |
| Stock-Based Compensation | $23.20M | $24.50M | $21.20M | $18.50M | $17.10M | $15.40M | $10.30M | $17.30M |
| Change in Payables | -$1.40M | $0 | $1.90M | -$4.60M | $2.90M | -$1.20M | -$1.10M | $3.50M |
| **Operating Cash Flow** | $7.30M | -$3.40M | -$600K | $20.70M | $4.50M | $5.50M | -$47.20M | $13.80M |
| Capital Expenditure | -$5.40M | -$4.60M | -$3.50M | -$3.10M | -$1.90M | -$2.10M | -$2.30M | -$3.20M |
| **Free Cash Flow** | $1.90M | -$8.00M | -$4.10M | $17.60M | $2.60M | $3.40M | -$49.50M | $10.60M |
| Purchases of Investments | -$23.40M | -$262.8M | -$150.7M | -$108.9M | -$191.0M | -$101.2M | -$75.60M | -$64.50M |
| **Investing Cash Flow** | -$29.30M | -$32.20M | -$34.60M | -$18.90M | -$59.40M | $29.50M | -$40.30M | $2.50M |
| **Financing Cash Flow** | $28.00M | $28.20M | $26.20M | $38.50M | $24.00M | $24.10M | $20.00M | $35.00M |
| **Net Change in Cash** | $4.90M | -$6.20M | -$10.30M | $41.30M | -$30.50M | $66.30M | -$66.00M | $47.90M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Net Profit Margin** | -22.4% | -38.4% | -55.1% | -116.0% | -187.9% | -129.6% | -161.2% | -235.1% |
| Return on Equity (ROE) | -31.0% | -34.1% | -33.4% | -34.4% | -24.4% | -22.6% | -- | -- |
| Return on Assets (ROA) | -8.6% | -10.9% | -14.5% | -17.6% | -16.0% | -14.8% | -26.2% | -- |
| Debt to Equity | 0.04x | 0.04x | 0.04x | 0.04x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | +40.2% | +22.5% | +67.4% | +99.9% | +36.0% | +40.3% | +199.1% | -- |
| 5Y Revenue / Share Growth | +255.8% | +22.5% | +199.8% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Net Profit Margin** | -13.0% | -14.2% | -16.4% | -22.4% | -26.4% | -34.0% | -38.9% | -38.4% |
| Return on Equity (ROE) | -30.6% | -27.7% | -26.8% | -31.0% | -33.7% | -38.7% | -39.8% | -34.1% |
| Return on Assets (ROA) | -6.9% | -6.9% | -7.1% | -8.6% | -9.1% | -10.5% | -11.7% | -10.9% |
| Debt to Equity | 0.04x | 0.04x | 0.04x | 0.04x | 0.02x | 0.04x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | +72.8% | +79.4% | +70.6% | +53.3% | +42.4% | +34.5% | +27.0% | +28.8% |
| Operating Cash Flow Growth (YoY) | +62.2% | -161.8% | -- | +50.0% | -72.4% | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -26.9% | -335.3% | -- | +66.0% | -81.6% | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
